187 related articles for article (PubMed ID: 36678612)
1. BIreactive: Expanding the Scope of Reactivity Predictions to Propynamides.
Hermann MR; Tautermann CS; Sieger P; Grundl MA; Weber A
Pharmaceuticals (Basel); 2023 Jan; 16(1):. PubMed ID: 36678612
[TBL] [Abstract][Full Text] [Related]
2. Expanding the Armory: Predicting and Tuning Covalent Warhead Reactivity.
Lonsdale R; Burgess J; Colclough N; Davies NL; Lenz EM; Orton AL; Ward RA
J Chem Inf Model; 2017 Dec; 57(12):3124-3137. PubMed ID: 29131621
[TBL] [Abstract][Full Text] [Related]
3. BIreactive: A Machine-Learning Model to Estimate Covalent Warhead Reactivity.
Palazzesi F; Hermann MR; Grundl MA; Pautsch A; Seeliger D; Tautermann CS; Weber A
J Chem Inf Model; 2020 Jun; 60(6):2915-2923. PubMed ID: 32250627
[TBL] [Abstract][Full Text] [Related]
4. The expanding repertoire of covalent warheads for drug discovery.
Mehta NV; Degani MS
Drug Discov Today; 2023 Dec; 28(12):103799. PubMed ID: 37839776
[TBL] [Abstract][Full Text] [Related]
5. Comparative reactivity analysis of small-molecule thiol surrogates.
Petri L; Ábrányi-Balogh P; Varga PR; Imre T; Keserű GM
Bioorg Med Chem; 2020 Apr; 28(7):115357. PubMed ID: 32081630
[TBL] [Abstract][Full Text] [Related]
6. Electrophilic warheads in covalent drug discovery: an overview.
Péczka N; Orgován Z; Ábrányi-Balogh P; Keserű GM
Expert Opin Drug Discov; 2022 Apr; 17(4):413-422. PubMed ID: 35129005
[TBL] [Abstract][Full Text] [Related]
7. Covalent inhibitor reactivity prediction by the electrophilicity index-in and out of scope.
Hermann MR; Pautsch A; Grundl MA; Weber A; Tautermann CS
J Comput Aided Mol Des; 2021 Apr; 35(4):531-539. PubMed ID: 33015740
[TBL] [Abstract][Full Text] [Related]
8. A Fast Ab Initio Predictor Tool for Covalent Reactivity Estimation of Acrylamides.
Palazzesi F; Grundl MA; Pautsch A; Weber A; Tautermann CS
J Chem Inf Model; 2019 Aug; 59(8):3565-3571. PubMed ID: 31246457
[TBL] [Abstract][Full Text] [Related]
9. A road map for prioritizing warheads for cysteine targeting covalent inhibitors.
Ábrányi-Balogh P; Petri L; Imre T; Szijj P; Scarpino A; Hrast M; Mitrović A; Fonovič UP; Németh K; Barreteau H; Roper DI; Horváti K; Ferenczy GG; Kos J; Ilaš J; Gobec S; Keserű GM
Eur J Med Chem; 2018 Dec; 160():94-107. PubMed ID: 30321804
[TBL] [Abstract][Full Text] [Related]
10. Characterising covalent warhead reactivity.
Martin JS; MacKenzie CJ; Fletcher D; Gilbert IH
Bioorg Med Chem; 2019 May; 27(10):2066-2074. PubMed ID: 30975501
[TBL] [Abstract][Full Text] [Related]
11. Covalent Docking in Drug Discovery: Scope and Limitations.
Scarpino A; Ferenczy GG; Keserű GM
Curr Pharm Des; 2020; 26(44):5684-5699. PubMed ID: 33155894
[TBL] [Abstract][Full Text] [Related]
12. Reactivities of acrylamide warheads toward cysteine targets: a QM/ML approach to covalent inhibitor design.
Danilack AD; Dickson CJ; Soylu C; Fortunato M; Rodde S; Munkler H; Hornak V; Duca JS
J Comput Aided Mol Des; 2024 May; 38(1):21. PubMed ID: 38693331
[TBL] [Abstract][Full Text] [Related]
13. Vinylpyridine as a Tunable Covalent Warhead Targeting C797 in EGFR.
Pemberton N; Compagne N; Argyrou A; Evertsson E; Gunnarsson A; Kettle JG; Orme JP; Ward RA
ACS Med Chem Lett; 2024 May; 15(5):583-589. PubMed ID: 38746885
[TBL] [Abstract][Full Text] [Related]
14. Binding Mode Prediction and Virtual Screening Applications by Covalent Docking.
Scarpino A; Ferenczy GG; Keserű GM
Methods Mol Biol; 2021; 2266():73-88. PubMed ID: 33759121
[TBL] [Abstract][Full Text] [Related]
15. Nitriles: an attractive approach to the development of covalent inhibitors.
Bonatto V; Lameiro RF; Rocho FR; Lameira J; Leitão A; Montanari CA
RSC Med Chem; 2023 Feb; 14(2):201-217. PubMed ID: 36846367
[TBL] [Abstract][Full Text] [Related]
16. Quantum Descriptors for Predicting and Understanding the Structure-Activity Relationships of Michael Acceptor Warheads.
Liu R; Vázquez-Montelongo EA; Ma S; Shen J
J Chem Inf Model; 2023 Aug; 63(15):4912-4923. PubMed ID: 37463342
[TBL] [Abstract][Full Text] [Related]
17. Systematic Exploration of Privileged Warheads for Covalent Kinase Drug Discovery.
Zhao Z; Bourne PE
Pharmaceuticals (Basel); 2022 Oct; 15(11):. PubMed ID: 36355497
[TBL] [Abstract][Full Text] [Related]
18. Drug discovery for a new generation of covalent drugs.
Kalgutkar AS; Dalvie DK
Expert Opin Drug Discov; 2012 Jul; 7(7):561-81. PubMed ID: 22607458
[TBL] [Abstract][Full Text] [Related]
19. Recent progress in covalent warheads for in vivo targeting of endogenous proteins.
Shindo N; Ojida A
Bioorg Med Chem; 2021 Oct; 47():116386. PubMed ID: 34509863
[TBL] [Abstract][Full Text] [Related]
20. An electrophilic warhead library for mapping the reactivity and accessibility of tractable cysteines in protein kinases.
Petri L; Egyed A; Bajusz D; Imre T; Hetényi A; Martinek T; Ábrányi-Balogh P; Keserű GM
Eur J Med Chem; 2020 Dec; 207():112836. PubMed ID: 32971426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
